R v Ingram
Case
•
[2018] NZCA 252
•13 July 2018
Details
AGLC
Case
Decision Date
R v Ingram [2018] NZCA 252
[2018] NZCA 252
13 July 2018
CaseChat Overview and Summary
The appellants, Alexander Ingram and Stephen Macris, were convicted of manufacturing MDA, a class A analogue of MDMA, a class B drug. The Court of Appeal considered whether the sentencing Judge was right to decline to apply the guideline judgment in R v Fatu in relation to methamphetamine, and instead to distinguish between class A drugs for sentencing purposes. The Court found that the sentencing Judge was correct to decline to apply Fatu, and that intra-class differentiation based on harm was an appropriate approach. The Court also considered the starting point for Mr Macris’ sentence and found it too high. Mr Macris’ appeal was allowed and his sentence was reduced to three years and 11 months’ imprisonment on all charges.
Details
Key Legal Topics
Areas of Law
-
Criminal Law
Legal Concepts
-
Sentencing
-
Appeal
-
Jurisdiction
-
Breach of Contract
-
Unjust Enrichment
Actions
Download as PDF
Download as Word Document
Citations
R v Ingram [2018] NZCA 252
Most Recent Citation
Cooper v The King [2025] NZHC 710
Cases Citing This Decision
12
Montoya-Ospina v The King
[2025] NZCA 112
Cavallo v R
[2022] NZCA 276
de Macedo v R
[2020] NZCA 132
Cases Cited
5
Statutory Material Cited
0
R v Kemp
[2008] QDC 65
R v Martinez
[2015] QCA 169
Everett v the Queen
[1994] HCA 49